user

WNDM Medical Inc. Announces Planned Reverse Stock Split and Company Name Change to Sanara MedTech Inc.

FORT WORTH, TX / ACCESSWIRE / March 25, 2019 / WNDM Medical Inc. (OTCQB: WNDM) Based in Fort Worth, Texas,…

6 years ago

Heads Up Checkup, Inc. to Present at the 146th NIBA Investment Conference

ANAHEIM HILLS, CA / ACCESSWIRE / March 25, 2019 / Heads Up Checkup, Inc., an emerging SAAS provider of mental…

6 years ago

Atlantic Weedboard to Present at the 146th NIBA Investment Conference

New York, NY / ACCESSWIRE / March 25, 2019 / Atlantic WeedBoard (www.atlanticWeedBoard.com), a newly formed information center for the…

6 years ago

Global Health & Pharma (”GHP”) Recognises InnerScope Hearing Technologies (OTCQB: INND) In the 2019 Biotechnology Awards Winners

UNITED KINGDOM / ACCESSWIRE / March 25, 2019 / GHP Magazine has awarded InnerScope Hearing Technologies, ("InnerScope") Best Hearing Aid…

6 years ago

Adial Pharmaceuticals Announces Filing to Update the Prior Registration Statement Registering the Shares Underlying the ADILW Warrants

CHARLOTTESVILLE, VA / ACCESSWIRE / March 25, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused…

6 years ago

AsclepiX Therapeutics, Inc. Strengthens Board of Directors, Welcomes Steven Altschuler, MD

AsclepiX Therapeutics, Inc., a biopharmaceutical company focused on developing novel peptide therapies, including AXT107 for retinal disease and novel peptides…

6 years ago

Glycotope Expands Phase Ib Trial of Combination of Proprietary Anti-Tumor Antibodies to Include Marketed Anti-Tumor Antibodies

- GATTO Study Extension to Evaluate Gatipotuzumab and Tomuzotuximab or marketed anti-EGFR Monoclonal Antibody Drugs in refractory metastatic solid tumors…

6 years ago

Kadmon Announces Susan Wiviott to Step Down from Board of Directors

NEW YORK, NY / ACCESSWIRE / March 22, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Susan Wiviott…

6 years ago

DNA Dynamics, Inc. Announces ”SunKissed Hemp” as Brand Name for its Hemp Products

NEW YORK, NY / ACCESSWIRE / March 22, 2019 / DNA Dynamics, Inc. (OTC PINK: DNAD) announces today that they…

6 years ago

CanadaBis Capital Inc. and 1926360 Alberta Ltd. (dba Stigma Pharmaceuticals) in the Final Stages of Proposed Amalgamation

CALGARY, AB / ACCESSWIRE / March 21, 2019 / CanadaBis Capital Inc. "TSXV: CANB.P" ("CanadaBis" or the "Company"), an Alberta…

6 years ago

Evotec AG to Report Fiscal Year 2018 Results on 28 March 2019

HAMBURG, GERMANY / ACCESSWIRE / March 21, 2019 / Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will report…

6 years ago

CorMedix Inc. Announces Appointment of Phoebe Mounts as Executive Vice President and General Counsel

BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 21, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on…

6 years ago

Hancock Jaffe Enrolls Four Additional Patients for First-in-Human VenoValve Study

Implantations to Take Place by End of April with Initial Data Expected in June 2019 IRVINE, CA / ACCESSWIRE /…

6 years ago

Heat Biologics to Present at the Chinese Society for Clinical Oncology Conference on Immunotherapy

DURHAM, NC / ACCESSWIRE / March 21, 2019 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing immunotherapies designed…

6 years ago

Alimera Sciences Announces Approval for ILUVIEN (R) in Kuwait

Kuwait Added to the Growing Number of Countries with Approval for ILUVIEN in the Middle East ATLANTA, GA / ACCESSWIRE…

6 years ago

Southbridge Fitness Center Announces its Grand Opening in Fort Greene, Brooklyn NY – Brooklyn Borough President Eric Adams to Speak at Grand Opening Celebration

Brooklyn Borough President Eric Adams to speak as Southbridge Fitness Center announces its grand opening on Myrtle Avenue in Fort…

6 years ago

NanoVibronix Announces Exclusive Agreement for Distribution of PainShield(R) and UroShield(R) in Italy

ELMSFORD, NY / ACCESSWIRE / March 20, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's…

6 years ago

Oryzon to Present Latest Advances of Vafidemstat at Oppenheimer’s 29th Annual Healthcare Conference

Highlighting encouraging preliminary first human data in REIMAGINE Phase IIa trial Complete data on Borderline Personality Disorder (BPD) cohort will…

6 years ago

Jaguar Completes Filing of CMC Technical Section with FDA for Use of Canalevia for Treatment of Chemotherapy-Induced Diarrhea in Dogs

SAN FRANCISCO, CA / ACCESSWIRE / March 20, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) (''Jaguar'' or the ''Company''), a…

6 years ago

Topas Therapeutics to Participate at Upcoming Industry and Scientific Conferences

HAMBURG / ACCESSWIRE / March 20, 2019 / Topas Therapeutics GmbH (Topas), a Hamburg, Germany-based private platform company leveraging the…

6 years ago